Ventilator-Associated Pneumonia in Pediatric Traumatic Brain Injury

Mitchell Hamele1, Chris Stockmann1, Meghan Cirulis1

  • 11 Department of Pediatrics, University of Utah School of Medicine , Salt Lake City, Utah.

Insights

Ventilator-associated pneumonia (VAP) is common in pediatric traumatic brain injury (TBI) patients. Treatments like barbiturate coma, neuromuscular blockade, and cooling blankets increase VAP risk, leading to longer hospital stays.

Area of Science:

  • Pediatric critical care medicine
  • Infectious disease epidemiology
  • Neurotrauma research

Background:

  • Ventilator-associated pneumonia (VAP) is a significant complication in intubated pediatric patients with moderate-to-severe traumatic brain injury (TBI).
  • Limited data exists on the specific epidemiology, risk factors, and causative microorganisms of VAP in this vulnerable population.
  • Understanding these factors is crucial for developing targeted prevention and treatment strategies.

Purpose of the Study:

  • To investigate the incidence, risk factors, microbiology, and clinical outcomes of VAP in pediatric patients with moderate-to-severe TBI.
  • To identify specific treatments or patient characteristics associated with an increased risk of developing VAP.
  • To inform clinical practice regarding the early management of VAP in this cohort.

Main Methods:

  • Retrospective cohort review of 119 pediatric patients with moderate-to-severe TBI.
  • Identification of VAP cases through positive protected bronchial brush specimens.
  • Multivariable analysis to determine independent risk factors for VAP development.

Main Results:

  • VAP was identified in 42 patients (35%).
  • Barbiturate coma (HR 3.2), neuromuscular blockade (NMBA; HR 3.4), and cooling blankets (HR 2.4) were independently associated with increased VAP risk.
  • Common pathogens included Methicillin-sensitive Staphylococcus aureus (34%), Haemophilus influenzae (22%), and Streptococcus pneumoniae (15%). Most VAP occurred early (before Day 4).
  • VAP was associated with longer ICU and hospital stays and increased need for chronic care, but not mortality.

Conclusions:

  • VAP is a frequent complication in pediatric TBI patients, often occurring early in the hospital course.
  • Specific intensive care interventions, including barbiturate coma, NMBA, and cooling blankets, are significant risk factors for VAP.
  • Early empiric antibiotic therapy for high-risk patients may help reduce morbidity associated with VAP in pediatric TBI.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
1.1K
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
856
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.5K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.2K